Becker's Hospital Review | Healthcare News & Analysis

Author's posts

Drugmaker, 2 executives to pay $40M to settle misleading claims allegations

Biopharmaceutical company Cassava Sciences, along with founder Remi Barbier and former Senior Vice President of Neuroscience Lindsay Burns, PhD, will pay more than $40 million to settle allegations related to misleading claims about a clinical trial fo…

Sentara cuts 200 positions, cites Medicaid redeterminations

Norfolk, Va.-based Sentara Health is cutting about 200 positions, with a majority of the cuts coming from its health plan division. 

Surgeon-CEO drives Insight's rapid expansion into multistate system

Flint, Mich.-based Insight Health System launched as a small physician office in 2006 and has evolved into a multistate hospital system with more than 5,000 employees and $450 million in revenue. 

Texas health system confirms ransomware attack: 6 things to know

A Texas health system is experiencing a ransomware attack. Here are six things to know.

Dana-Farber to lead pediatric cancer consortium: 5 notes

Boston-based Dana-Farber Cancer Institute will lead 12 other health systems and academic institutions across the U.S. in a new cancer consortium aimed at addressing health equity and survival rates among pediatric populations.

White House unveils new efforts to curb gun violence: 3 healthcare takeaways

The Biden administration on Sept. 26 unveiled a suite of new efforts to combat gun violence, including directives to ensure healthcare providers are reimbursed for firearm safety counseling. 

CommonSpirit California region to get new regional CMIO

Monique Díaz, MD, will assume the role of vice president and regional chief medical information officer for CommonSpirit Health’s California region, according to her LinkedIn. 

The power of pause, per 1 Northwell hospital president

When pushing through a difficult time, it is crucial for leaders to ensure the rest of their team is moving forward with them, Jon Sendach, president of Manhasset, N.Y.-based North Shore University Hospital, told Becker’s.

FDA approves schizophrenia treatment

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. 

Unionization picks up after 'pharmageddon': 4 things to know

In the wake of 2023 walkouts by pharmacy workers dubbed “pharmageddon,” major chains such as Walgreens and CVS are facing increased pressure from their employees to provide better working conditions and wages.